These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35599571)

  • 1. Hormone replacement therapy subcutaneous implants for refractory menopause symptoms; the patient's perspective.
    Dixit A; Carden N; Stephens E; Chadwick M; Tamblyn J; Robinson L
    Post Reprod Health; 2022 Jun; 28(2):79-91. PubMed ID: 35599571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study.
    Pearce J; Hawton K; Blake F; Barlow D; Rees M; Fagg J; Keenan J
    J Psychosom Res; 1997 Feb; 42(2):177-86. PubMed ID: 9076645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Climacteric symptoms, age, and sense of coherence are associated with sexual function scores in women after menopause.
    Armeni A; Armeni E; Augoulea A; Stergiotis S; Kaparos G; Alexandrou A; Eleftheriadis M; Georgopoulos N; Vlahos N; Lambrinoudaki I
    J Sex Med; 2023 Feb; 20(3):313-323. PubMed ID: 36763958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The climacteric, osteoporosis and hormone replacement; views of women aged 45-49.
    Garton M; Reid D; Rennie E
    Maturitas; 1995 Jan; 21(1):7-15. PubMed ID: 7731387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial factors, attitude to menopause and symptoms in Swedish perimenopausal women.
    Olofsson AS; Collins A
    Climacteric; 2000 Mar; 3(1):33-42. PubMed ID: 11910608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale.
    Sierra B; Hidalgo LA; Chedraui PA
    Maturitas; 2005 Jul; 51(3):236-45. PubMed ID: 15978967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal Hormone Therapy, an Ever-Present Topic: A Pilot Survey about Women's Experience and Medical Doctors' Approach.
    Aquino CI; Stampini V; Osella E; Troìa L; Rocca C; Guida M; Faggiano F; Remorgida V; Surico D
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792957
    [No Abstract]   [Full Text] [Related]  

  • 9. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status.
    Travers C; O'Neill SM; King R; Battistutta D; Khoo SK
    Climacteric; 2005 Mar; 8(1):56-62. PubMed ID: 15804732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survey on characteristics of menopause of Chinese women with the age of 40-60 years at gynecological clinic from 14 hospitals].
    Chen R; Yu Q; Xu KH; Xie MQ; Lei XM; Ren ML; Ruan XY; Ding Y; Fu SX; Yang X; Lin Y; Wang HL; Wu YY; Zhang SF; Guo XT
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):723-7. PubMed ID: 24406126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
    Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
    Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study.
    Stadberg E; Mattsson LA; Milsom I
    Maturitas; 1997 Jun; 27(2):109-16. PubMed ID: 9255745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of food supplements among women attending menopause clinics in the West Midlands.
    Gokhale L; Sturdee DW; Parsons AD
    J Br Menopause Soc; 2003 Mar; 9(1):32-5. PubMed ID: 12804311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral symptoms at menopause--the role of hormone replacement therapy.
    Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the quality of life of women in the climacteric period].
    Skrzypulec V; Drosdzol A; Ferensowicz J
    Ginekol Pol; 2004 May; 75(5):373-81. PubMed ID: 15524411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.